Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,516,724
-
Share change
-
+557,949
-
Total reported value
-
$94,426,611
-
Put/Call ratio
-
120%
-
Price per share
-
$62.25
-
Number of holders
-
46
-
Value change
-
+$34,788,774
-
Number of buys
-
18
-
Number of sells
-
15
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2020
As of 30 Jun 2020,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,516,724 shares.
The largest 10 holders included
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), GOLDMAN SACHS GROUP INC, CLS Investments, LLC, Orion Portfolio Solutions, LLC, ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Tower Research Capital LLC (TRC), and LPL Financial LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.